Drug scheduling in Norway is handled through a single official registry called the Narcotics List, which sits inside the Narcotics Regulation and is maintained by the Norwegian Medical Products Agency under the authority of the Medicinal Products Act. Any substance on that list is illegal to produce, import, sell, store, or possess without authorization, and the criminal penalties run from a fine at the low end up to 21 years in prison for the most serious trafficking offenses.
The Two Laws Behind the System
Norwegian drug control rests on two pieces of legislation working together. The Medicinal Products Act (legemiddelloven), originally enacted in 1992, gives the government the authority to classify substances as narcotics and regulate how they are made, sold, and handled.1Regjeringen.no. Norwegian Drug Policy in International Fora It also carries its own penalty provisions for regulatory violations.
The operational detail lives in the Narcotics Regulation (Narkotikaforskriften), issued by the Ministry of Health and Care Services in February 2013. This regulation spells out the rules for manufacturing, selling, importing, exporting, storing, possessing, and using narcotics, and it contains the Narcotics List itself. The regulation was most recently amended effective January 1, 2026.2Lovdata. Forskrift om Narkotika (Narkotikaforskriften)
What’s on the Narcotics List
The Narcotics List (Narkotikalisten) is the official registry of every controlled substance in Norway. At its core, it includes every substance covered by the UN Single Convention on Narcotic Drugs of 1961 and the Convention on Psychotropic Substances of 1971, which keeps Norway aligned with its treaty obligations.1Regjeringen.no. Norwegian Drug Policy in International Fora Beyond the treaty-controlled substances, Norwegian authorities add compounds showing signs of abuse or particular harm domestically, even when no UN convention covers them.
Each entry carries a specific chemical designation and CAS number. The regulation’s definition of “narcotic” is deliberately wide: it covers any listed substance, plus salts, stereoisomers, esters, and ethers of listed substances that have a psychoactive effect, and any mixture containing a listed substance.2Lovdata. Forskrift om Narkotika (Narkotikaforskriften)
Generic Group Scheduling
One of the more aggressive features of the Norwegian approach is scheduling by chemical family. When the regulation was rewritten in 2013, the old method of listing individual substances plus their “derivatives” was dropped because the derivative concept proved too vague to prosecute reliably. In its place came structural definitions covering broad chemical groups, including synthetic cannabinoids, cathinones, phenethylamines, and tryptamines.3European Union Drugs Agency. Controlling New Psychoactive Substances The current list defines 12 such groups, including benzoylindoles, fentanyls, and nitazenes.2Lovdata. Forskrift om Narkotika (Narkotikaforskriften)
The effect is that any new compound fitting the structural definition of a controlled group is automatically illegal, without requiring a fresh listing every time a clandestine chemist alters a molecule. This closes the usual gap between a designer drug reaching the street and being formally banned.
Who Decides What Gets Scheduled
The Norwegian Medical Products Agency (DMP, known internationally as NOMA) administers the narcotics regulations day to day. It classifies substances, maintains the list, and issues import and export permits for narcotic medications.4Norwegian Medical Products Agency. Goals and Tasks of the Norwegian Medical Products Agency The agency also tracks domestic and international drug trends to identify emerging psychoactive substances early.
When a new compound raises concern, the agency compiles pharmacological data on its effects on the central nervous system, dependence potential, and abuse evidence drawn from law enforcement seizures and clinical reports. It then assesses health and social risks, often looking at how neighboring countries and international health bodies handle the same substance.
The agency sends its formal recommendation to the Ministry of Health and Care Services, which reviews the findings against national health policy. A public consultation period typically follows. If the Ministry accepts the recommendation, it issues an administrative decree amending the Narcotics Regulation, and the updated text is published in Norsk Lovtidend, Norway’s official law gazette.5European Forum of Official Gazettes. Norway Enforcement begins on publication or on the date specified in the decree.
Criminal Penalties for Drug Offenses
While the Medicinal Products Act contains its own penalty provisions for regulatory breaches, the serious criminal consequences live in Chapter 23 of Norway’s Penal Code (Straffeloven). The penalties scale sharply with the seriousness of the offense.
Standard Offenses Under Section 231
Unlawfully producing, importing, exporting, acquiring, storing, sending, or supplying a narcotic substance carries a maximum penalty of two years in prison or a fine. If the offense was negligent rather than intentional, the maximum drops to one year.6Lovdata. The Penal Code – Chapter 23 – Sections 231-232 These provisions cover the full range of drug handling.
Aggravated Offenses Under Section 232
When an offense is aggravated, the penalties jump. Courts weigh three factors: the type of substance, the quantity, and the nature of the offense. The tiers are:
- Aggravated offense: up to 10 years in prison.
- Very substantial quantity: between 3 and 15 years, with 3 years as a mandatory minimum.
- Especially aggravated circumstances: up to 21 years, which is the ceiling for any crime under Norwegian law.
- Negligent aggravated offense: up to 6 years.
The Penal Code does not fix weight thresholds for each drug. Courts set those boundaries through case law, weighing the type and amount of the substance alongside factors like whether the offender played an organizing role or whether the operation crossed borders.6Lovdata. The Penal Code – Chapter 23 – Sections 231-232
Personal Use After the 2022 Supreme Court Rulings
Norwegian law does not formally decriminalize personal drug use. Possession and use remain illegal under the Narcotics Regulation. What has changed is how those offenses are handled in practice for people with addiction.
In 2021, the government proposed a broader reform (the rusreformen) that would have removed criminal penalties for personal use of small quantities and shifted the response to a mandatory meeting with a municipal advisory service. The proposal failed in parliament when the Labour Party opposed general decriminalization, although the party supported lighter treatment for people with serious addiction.7National Policies Platform. Norway – Current Debates and Reforms
The Supreme Court then reached part of that outcome by ruling in 2022 that people suffering from drug addiction should no longer be fined for using or possessing drugs for personal use. The appropriate response for addicted individuals is a waiver of sentencing or a waiver of prosecution. The Director of Public Prosecutions issued new guidelines for police and prosecutors after those rulings.8Norwegian National Human Rights Institution. Drug Use and Human Rights The result is a two-track system. Heavy users with addiction are largely diverted away from criminal punishment. Recreational users without an addiction diagnosis still face potential fines or short sentences under Section 231.
Prosecution guidelines have historically treated “one to two user doses” as the general threshold for personal possession. For specific substances, the amounts considered consistent with personal use have been reported as roughly 10 to 15 grams of cannabis, 5 tablets of ecstasy, and 0.5 grams of heroin or cocaine. These figures are prosecutorial guidelines, not fixed statutory limits.
A Boundary Worth Knowing: CBD and Cannabis
All CBD products made from cannabis extracts are classified as narcotics in Norway, regardless of THC content. Norwegian drug law follows the UN conventions in regulating all cannabis extracts, so there is no legal distinction between high-THC cannabis and a THC-free CBD oil derived from hemp. Carrying a CBD product into Norway without a valid prescription and proper documentation falls under the same import rules as any other narcotic.9Norwegian Medical Products Agency. Bringing Medicines into Norway by Travel Medical cannabis is available, but only through a restricted named-patient approval that a doctor must obtain from the Medical Products Agency.